Preimplantation Genetic Testing Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2024 to 2034
In today’s fast-paced business environment, organizations must rely on accurate insights and structured data to remain competitive and sustainable. Recognizing this growing demand, Emergen Research has introduced its advanced Preimplantation Genetic Testing market research content, a comprehensive solution designed to help businesses understand evolving market trends and ... morePreimplantation Genetic Testing Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2024 to 2034
In today’s fast-paced business environment, organizations must rely on accurate insights and structured data to remain competitive and sustainable. Recognizing this growing demand, Emergen Research has introduced its advanced Preimplantation Genetic Testing market research content, a comprehensive solution designed to help businesses understand evolving market trends and make informed strategic decisions. This offering is built to support companies across various industries by providing meaningful insights and practical guidance.
A key strength of this research lies in its ability to simplify complex data into actionable knowledge. Businesses often struggle with interpreting large volumes of information, but this content is designed to present insights in a clear and structured manner. By focusing on usability, the report ensures that decision-makers can quickly understand the data and apply it effectively to their strategies.
Preimplantation Genetic Testing Market Size and Overview
The preimplantation genetic testing market is expected to grow from an estimated USD 0.8 billion in 2024 to USD 2.2 billion in 2033, at a CAGR of 11.90%.
The global preimplantation genetic testing market size is expected to grow from 0.8 billion by the end of 2024 to 2.2 billion by 2033, registering a revenue CAGR of 11.90% during the forecast period. Preimplantation genetic testing (PGT) is gaining significant attention within the global assisted reproductive technologies (ART) industry.
The advancement in PGT methods is driving better outcomes for families experiencing infertility, as it allows the identification of genetic conditions in embryos prior to implantation. According to the American Society for Reproductive Medicine (ASRM), the prevalence of genetic disorders, including aneuploidy and single gene disorders, has spurred the growth of the PGT market. Additionally, PGT procedures enable the selection of healthy embryos for implantation, which enhances pregnancy rates and reduces the risk of genetic diseases.
Furthermore, the increasing use of advanced technologies like next-generation sequencing (NGS) and fluorescence in situ hybridization (FISH) is contributing to the robust market growth. The market is further being propelled by rising awareness of genetic screening among patients and the availability of improved treatment options through fertility clinics and diagnostic laboratories.
Market trends indicate a growing preference for non-invasive methods and improved genetic testing solutions. For instance, a report by the International Society for Prenatal Diagnosis (ISPD) noted that over 15 million genetic testing procedures were conducted globally in 2023, showcasing the expanding need for genetic screening in reproductive health. This market expansion is also supported by technological innovations, such as single-nucleotide polymorphism (SNP) testing and advances in genomic analysis, which allow for more precise and reliable genetic profiling.
Another significant aspect of the Preimplantation Genetic Testing market research content is its emphasis on continuous innovation and expert-driven analysis. The research is developed by a team of experienced professionals who possess a deep understanding of industry dynamics. Their insights help businesses uncover hidden opportunities, understand competitive pressures, and anticipate future challenges.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4006
The report also explores key drivers influencing the market’s growth. Factors such as technological advancements, changing consumer behavior, and economic developments play a crucial role in shaping the Preimplantation Genetic Testing market. By analyzing these drivers, the report provides businesses with a clear understanding of what is fueling growth and how they can align their strategies accordingly.
By Procedure Type Outlook (Revenue, USD Billion; 2020-2033)Â
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
By Technology Outlook (Revenue, USD Billion; 2020-2033)Â
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Comparative Genomic Hybridization
Single-Nucleotide Polymorphism
By Product Outlook (Revenue, USD Billion; 2020-2033)Â
Reagents and Consumables
Instruments
Software and Services
By Application Outlook (Revenue, USD Billion; 2020-2033)Â
Aneuploidy
Structural Chromosomal Abnormalities
Single Gene Disorders
X-Linked Disorders
HLA Typing
Gender Identification
By Type of Cycle Outlook (Revenue, USD Billion; 2020-2033)Â
Fresh Non-Donor
Frozen Non-Donor
Fresh Donor
Frozen Donor
By End User Outlook (Revenue, USD Billion; 2020-2033)Â
Fertility Clinics
Hospitals
Diagnostic Laboratories
Other End Users
By Regional Outlook (Revenue, USD Billion; 2020-2033)Â
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
In addition to growth drivers, the report highlights the importance of strategic planning and adaptability. Businesses that remain flexible and responsive to market changes are more likely to succeed in a competitive landscape. Emergen Research ensures that its content reflects the latest market conditions, allowing organizations to stay updated and make timely decisions.
Market Segmentation:
The segmentation analysis included in the report provides valuable insights into different market categories. By examining various segments based on product types, applications, and end-user industries, businesses can identify high-potential areas and focus their efforts accordingly. This targeted approach helps improve efficiency and maximize returns.
The preimplantation genetic testing market is having high competition, with several key players offering a wide range of services and technological advancements. Major players include Illumina, Inc., Thermo Fisher Scientific, LabCorp, and PGT Healthcare, which lead the market with cutting-edge genetic testing solutions for preimplantation diagnostics and screening. These companies focus on expanding their product portfolios through strategic acquisitions, partnerships, and technological innovations to stay ahead in the market.
For instance, in January 2024, Illumina announced a collaboration with Genomics England to advance preimplantation genetic testing methods, aiming to improve genetic screening accuracy and enhance IVF success rates. Such collaborations are expected to drive growth and solidify market leadership for these companies in the coming years.
Some of the key companies in the global Preimplantation Genetic Testing Market include:
Ferring Pharmaceuticals
Illumina, Inc.
Genomic Health, Inc.
Invitae Corporation
Thermo Fisher Scientific
Agilent Technologies, Inc.
Genesis Genetics
CooperSurgical, Inc.
Prevention Genetics
Reproductive Medicine Associates (RMA)
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4006
Competitive Landscape:
Understanding competition is another critical component of the research. The report offers a comprehensive analysis of the competitive landscape, highlighting key players and their strategies. It examines recent developments such as mergers, acquisitions, partnerships, and product innovations, providing businesses with valuable insights into how competitors are positioning themselves.
Growing Demand for Genetic Screening in Reproductive Health
The increasing demand for preimplantation genetic testing (PGT) is driven by growing awareness among patients and healthcare professionals regarding genetic diseases and their impact on reproductive outcomes. The rise in infertility rates, particularly in developed countries, is contributing to a heightened focus on genetic screening procedures.
According to the Centers for Disease Control and Prevention (CDC), approximately 12% of women in the United States aged 15-44 years have difficulty conceiving or carrying a pregnancy to term, highlighting the need for assisted reproductive technologies (ART) such as PGT. Furthermore, the increasing prevalence of genetic disorders, including aneuploidy, single-gene disorders, and structural chromosomal abnormalities, is prompting more families to seek genetic testing solutions during their fertility treatments.
As a result, fertility clinics and hospitals are adopting advanced genetic testing methods to ensure better outcomes for patients. The demand for PGT is also being supported by improved clinical outcomes, as PGT helps in identifying embryos without genetic abnormalities, thereby improving the chances of successful pregnancies.
In addition, advancements in genomic technologies, such as next-generation sequencing (NGS), have enhanced the accuracy and efficiency of genetic testing, further driving market growth. The integration of artificial intelligence (AI) and machine learning (ML) technologies in PGT platforms is expected to revolutionize the market by providing more accurate predictions of genetic disorders.
For instance, in September 2023, Invitae Corporation, a leader in genetic testing, launched a new PGT service that utilizes AI-driven algorithms to predict chromosomal abnormalities with higher accuracy, thereby increasing the success rates of assisted reproductive treatments.
The Preimplantation Genetic Testing market research content also includes a wide range of resources, including detailed reports, case studies, whitepapers, and trend analyses. These materials cover multiple industries such as healthcare, technology, finance, and manufacturing, making the content highly versatile and applicable across different sectors.
Another notable feature of the report is its focus on delivering actionable recommendations. Businesses can use these insights to improve their operations, enhance customer experience, and develop effective marketing strategies. The recommendations are tailored to address specific challenges and opportunities, ensuring that they are relevant and practical.
The research is designed to cater to a diverse audience, including investors, enterprises, consultants, and policymakers. Each group can benefit from the insights provided, whether it is for identifying investment opportunities or developing strategic plans.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/preimplantation-genetic-testing-market
About Emergen Research
Emergen Research is a leading provider of market research and consulting services, offering data-driven insights and strategic guidance to help businesses succeed in a competitive environment.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
